logo-loader
viewArcadia Biosciences Inc

Arcadia Biosciences' new focus on health and nutrition to increase revenue growth

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar and CFO Matt Plavan tells Proactive Investors that the company is transitioning to a new health and nutrition business model from an old R&D-focused business.

Ketkar says first sales of its GoodWheat product combined and advancing its cannabis business should contribute to greater revenue growth into 2020.

Quick facts: Arcadia Biosciences Inc

Price: 3.72 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $39.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Arcadia Biosciences raises $6.8M to fund hemp opportunities, cushion from...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matt Plavan tells Proactive that the agricultural technology company has raised about $6.8 million by selling warrants. Plavan says the company expects to use the proceeds to pursue a range of near-term inorganic growth opportunities within its hemp...

on 05/18/2020

2 min read